24.25
price down icon2.38%   -0.59
after-market Dopo l'orario di chiusura: 24.25
loading
Precedente Chiudi:
$24.84
Aprire:
$24.4
Volume 24 ore:
1.18M
Relative Volume:
0.78
Capitalizzazione di mercato:
$2.09B
Reddito:
$1.13B
Utile/perdita netta:
$62.75M
Rapporto P/E:
38.49
EPS:
0.63
Flusso di cassa netto:
$170.92M
1 W Prestazione:
-4.45%
1M Prestazione:
-6.01%
6M Prestazione:
+4.93%
1 anno Prestazione:
+5.66%
Intervallo 1D:
Value
$23.94
$24.60
Intervallo di 1 settimana:
Value
$23.94
$25.78
Portata 52W:
Value
$17.98
$28.75

Progyny Inc Stock (PGNY) Company Profile

Name
Nome
Progyny Inc
Name
Telefono
212-888-3124
Name
Indirizzo
1359 BROADWAY, NEW YORK, NY
Name
Dipendente
680
Name
Cinguettio
@Progyny
Name
Prossima data di guadagno
2024-11-12
Name
Ultimi documenti SEC
Name
PGNY's Discussions on Twitter

Confronta PGNY con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Healthcare Plans icon
PGNY
Progyny Inc
24.25 2.14B 1.13B 62.75M 170.92M 0.63
Healthcare Plans icon
UNH
Unitedhealth Group Inc
282.70 318.53B 435.16B 18.37B 17.37B 19.16
Healthcare Plans icon
CVS
Cvs Health Corp
72.00 106.47B 393.94B 428.00M 6.29B 0.3826
Healthcare Plans icon
CI
Cigna Group
270.09 74.90B 268.22B 6.55B 7.44B 22.67
Healthcare Plans icon
ELV
Elevance Health Inc
322.92 83.77B 194.82B 5.53B 3.77B 24.45
Healthcare Plans icon
HUM
Humana Inc
207.93 31.71B 126.36B 1.30B 1.55B 10.67

Progyny Inc Stock (PGNY) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2026-01-20 Aggiornamento Citizens JMP Mkt Perform → Mkt Outperform
2026-01-08 Aggiornamento Truist Hold → Buy
2025-12-09 Iniziato Barclays Overweight
2025-11-12 Aggiornamento KeyBanc Capital Markets Sector Weight → Overweight
2025-07-08 Aggiornamento Leerink Partners Market Perform → Outperform
2024-12-02 Downgrade JP Morgan Overweight → Neutral
2024-11-13 Downgrade Truist Buy → Hold
2024-09-19 Downgrade JMP Securities Mkt Outperform → Mkt Perform
2024-08-07 Downgrade BTIG Research Buy → Neutral
2024-08-07 Downgrade Canaccord Genuity Buy → Hold
2024-08-07 Downgrade Leerink Partners Outperform → Market Perform
2024-07-16 Iniziato JMP Securities Mkt Outperform
2024-05-10 Downgrade KeyBanc Capital Markets Overweight → Sector Weight
2024-02-26 Iniziato Leerink Partners Outperform
2024-01-03 Iniziato Barclays Overweight
2023-09-27 Iniziato Canaccord Genuity Buy
2023-05-22 Iniziato BTIG Research Buy
2023-04-21 Iniziato Cantor Fitzgerald Overweight
2023-01-05 Downgrade SVB Leerink Outperform → Mkt Perform
2022-09-16 Iniziato KeyBanc Capital Markets Overweight
2022-09-07 Iniziato Truist Buy
2021-12-02 Iniziato Jefferies Buy
2021-11-22 Downgrade Citigroup Buy → Neutral
2021-09-30 Iniziato Berenberg Buy
2021-08-12 Iniziato Barclays Overweight
2021-06-02 Downgrade Guggenheim Buy → Neutral
2021-04-29 Ripresa JP Morgan Overweight
2021-03-10 Aggiornamento BofA Securities Neutral → Buy
2020-07-01 Iniziato SVB Leerink Outperform
2020-06-02 Iniziato Guggenheim Buy
2019-11-19 Iniziato Citigroup Buy
2019-11-19 Iniziato Goldman Buy
2019-11-19 Iniziato JP Morgan Overweight
2019-11-19 Iniziato Piper Jaffray Overweight
2019-11-19 Iniziato SVB Leerink Outperform
Mostra tutto

Progyny Inc Borsa (PGNY) Ultime notizie

pulisher
Jan 27, 2026

Kornitzer Capital Management Inc. KS Sells 85,000 Shares of Progyny, Inc. $PGNY - MarketBeat

Jan 27, 2026
pulisher
Jan 27, 2026

Progyny Inc (NASDAQ:PGNY) Combines Strong Fundamentals with Bullish Technical Setup - Chartmill

Jan 27, 2026
pulisher
Jan 26, 2026

Published on: 2026-01-27 11:06:26 - baoquankhu1.vn

Jan 26, 2026
pulisher
Jan 25, 2026

US Market Recap: Why is Progyny Inc stock going downMarket Movers & AI Powered Buy/Sell Recommendations - baoquankhu1.vn

Jan 25, 2026
pulisher
Jan 23, 2026

Bull Run: Is Progyny Inc forming a bullish divergenceMarket Activity Report & Precise Swing Trade Alerts - baoquankhu1.vn

Jan 23, 2026
pulisher
Jan 23, 2026

Progyny, Inc. (PGNY) supported by analysts as earnings visibility improves - MSN

Jan 23, 2026
pulisher
Jan 23, 2026

Hedge Fund Bets: How do insiders feel about ProShares Trust ProShares Ultra SemiconductorsJuly 2025 Price Swings & Expert Approved Trade Ideas - baoquankhu1.vn

Jan 23, 2026
pulisher
Jan 22, 2026

Wall Street Recap: What analysts say about Progyny Inc stockTrade Risk Assessment & Risk Adjusted Buy and Sell Alerts - baoquankhu1.vn

Jan 22, 2026
pulisher
Jan 22, 2026

Progyny price target raised to $35 from $30 at BTIG - Yahoo Finance

Jan 22, 2026
pulisher
Jan 22, 2026

SG Americas Securities LLC Cuts Stock Position in Progyny, Inc. $PGNY - MarketBeat

Jan 22, 2026
pulisher
Jan 22, 2026

Progyny, Inc. (PGNY) Supported by Analysts as Earnings Visibility Improves - Yahoo Finance

Jan 22, 2026
pulisher
Jan 21, 2026

Progyny Shows Rising Price Performance With Jump To 82 RS Rating - Investor's Business Daily

Jan 21, 2026
pulisher
Jan 20, 2026

ETF Watch: Is Progyny Inc stock technically oversold2025 EndofYear Setup & Short-Term High Return Strategies - baoquankhu1.vn

Jan 20, 2026
pulisher
Jan 20, 2026

Progyny (PGNY) Stock Rises on Analyst Upgrade to Market Outperform | 2026 OutlookNews and Statistics - IndexBox

Jan 20, 2026
pulisher
Jan 20, 2026

Progyny (PGNY) Stock Is Up, What You Need To Know - Finviz

Jan 20, 2026
pulisher
Jan 20, 2026

Progyny sees IBD RS rating climb to 77 - MSN

Jan 20, 2026
pulisher
Jan 20, 2026

Forecasting The Future: 6 Analyst Projections For Progyny - Benzinga

Jan 20, 2026
pulisher
Jan 20, 2026

Progyny (NASDAQ:PGNY) Upgraded by Citizens Jmp to "Market Outperform" Rating - MarketBeat

Jan 20, 2026
pulisher
Jan 20, 2026

Citizens Upgrades Progyny (PGNY) - Nasdaq

Jan 20, 2026
pulisher
Jan 20, 2026

PGNY Stock Rating Upgraded by Citizens to Market Outperform | PG - GuruFocus

Jan 20, 2026
pulisher
Jan 20, 2026

Progyny stock rating upgraded by Citizens on strong retention rates - Investing.com Canada

Jan 20, 2026
pulisher
Jan 20, 2026

This Intel Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Tuesday - Benzinga

Jan 20, 2026
pulisher
Jan 20, 2026

Progyny Sees IBD RS Rating Climb To 77 - Investor's Business Daily

Jan 20, 2026
pulisher
Jan 19, 2026

Progyny president’s employment to end December 2025 - MSN

Jan 19, 2026
pulisher
Jan 18, 2026

Short Interest in Progyny, Inc. (NASDAQ:PGNY) Declines By 23.3% - MarketBeat

Jan 18, 2026
pulisher
Jan 17, 2026

(PGNY) Movement as an Input in Quant Signal Sets - Stock Traders Daily

Jan 17, 2026
pulisher
Jan 17, 2026

Can Progyny’s (PGNY) Modest Guidance Raise Redefine Its Demand Resilience Narrative? - Yahoo Finance

Jan 17, 2026
pulisher
Jan 16, 2026

Stock Picks for 2026: e.l.f. Beauty to Buy, American Woodmark & Progyny to SellNews and Statistics - IndexBox

Jan 16, 2026
pulisher
Jan 16, 2026

Pullback Watch: Why is Progyny Inc stock going downJuly 2025 Levels & Free Weekly Watchlist of Top Performers - baoquankhu1.vn

Jan 16, 2026
pulisher
Jan 15, 2026

Progyny Inc (PGNY) Shares Gap Down to $24.7608 on Jan 15 - GuruFocus

Jan 15, 2026
pulisher
Jan 14, 2026

Aug Setups: Is Progyny Inc impacted by rising rates2025 Bull vs Bear & Expert Curated Trade Setups - baoquankhu1.vn

Jan 14, 2026
pulisher
Jan 14, 2026

Analysts Offer Insights on Healthcare Companies: Boston Scientific (BSX), Regeneron (REGN) and Progyny (PGNY) - The Globe and Mail

Jan 14, 2026
pulisher
Jan 14, 2026

Progyny (NASDAQ:PGNY) Reaches New 1-Year HighTime to Buy? - MarketBeat

Jan 14, 2026
pulisher
Jan 14, 2026

Progyny Stock (-11%) : JPM Conference Growth Narrative Fails to Impress - Trefis

Jan 14, 2026
pulisher
Jan 14, 2026

Progyny, Inc. (NASDAQ:PGNY) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat

Jan 14, 2026
pulisher
Jan 13, 2026

Progyny (NASDAQ:PGNY) Shares Down 5.9%Time to Sell? - MarketBeat

Jan 13, 2026
pulisher
Jan 13, 2026

Progyny, Inc.'s (NASDAQ:PGNY) Stock Is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue? - 富途牛牛

Jan 13, 2026
pulisher
Jan 12, 2026

Progyny stock to exceed guidance as BofA reiterates Buy rating By Investing.com - Investing.com Canada

Jan 12, 2026
pulisher
Jan 12, 2026

Progyny stock to exceed guidance as BofA reiterates Buy rating - Investing.com

Jan 12, 2026
pulisher
Jan 12, 2026

Zacks Industry Outlook Highlights Medpace, Enhabit and Progyny - Yahoo Finance

Jan 12, 2026
pulisher
Jan 12, 2026

Progyny to discuss updated financial expectations at upcoming JP Morgan healthcare conference - marketscreener.com

Jan 12, 2026
pulisher
Jan 12, 2026

Progyny To Discuss Updated Financial Expectations At Upcoming JP Morgan Healthcare Conference - TradingView

Jan 12, 2026
pulisher
Jan 12, 2026

Progyny Inc anticipates Q4 and full year results to be slightly above previously provided financial guidance - marketscreener.com

Jan 12, 2026
pulisher
Jan 12, 2026

Progyny to Discuss Updated Financial Expectations at Upcoming JP Morgan Healthcare Conference - The Manila Times

Jan 12, 2026
pulisher
Jan 12, 2026

Family-building firm Progyny now expects stronger year-end results - Stock Titan

Jan 12, 2026
pulisher
Jan 11, 2026

Progyny, Inc.'s (NASDAQ:PGNY) Stock Is Rallying But Financials Look Ambiguous: Will The Momentum Continue? - Yahoo Finance

Jan 11, 2026
pulisher
Jan 10, 2026

Progyny (PGNY) Tops Q1 Earnings and Revenue Estimates - sharewise.com

Jan 10, 2026
pulisher
Jan 10, 2026

How sustainable is Progyny Inc. stock dividend payout2025 Trading Recap & Fast Moving Stock Watchlists - ulpravda.ru

Jan 10, 2026
pulisher
Jan 10, 2026

Why Progyny Inc. stock remains a top recommendationRisk Management & Low Risk Growth Stock Ideas - Улправда

Jan 10, 2026
pulisher
Jan 10, 2026

Progyny, Inc. (PGNY) Soars to 52-Week High, Time to Cash Out? - sharewise.com

Jan 10, 2026
pulisher
Jan 09, 2026

Progyny stock hits 52-week high at 27.84 USD By Investing.com - Investing.com Nigeria

Jan 09, 2026

Progyny Inc Azioni (PGNY) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$20.96
price down icon 11.97%
$14.88
price down icon 5.22%
healthcare_plans MOH
$184.12
price down icon 8.42%
healthcare_plans CNC
$41.53
price down icon 10.26%
healthcare_plans HUM
$207.93
price down icon 21.13%
Capitalizzazione:     |  Volume (24 ore):